ArticleCancer medicine2024

The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.

Jindřich Kopecký et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.